Comorbid substance abuse: Affects treatment for bipolar disorder

Psychiatric Annals

Volumn 34, Issue 1, 2004, Pages 41-45

  Lawson, William B ^a,b   Bland, Walter P ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; LAMOTRIGINE; LITHIUM; NALTREXONE; NEUROLEPTIC AGENT; ONDANSETRON; QUETIAPINE; SEROTONIN 3 ANTAGONIST; TOPIRAMATE; VALPROIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL ABUSE; ALCOHOLISM; BIPOLAR DISORDER; CHRONIC DISEASE; COCAINE DEPENDENCE; COMORBIDITY; DIAGNOSTIC ERROR; DISEASE COURSE; EVIDENCE BASED MEDICINE; HEPATITIS C; HUMAN; MENTAL DISEASE; PSYCHIATRIC DIAGNOSIS; RELAPSE; REVIEW; SUBSTANCE ABUSE;

EID: 2142661787     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-20040101-09     Document Type: Review

References (27)

1. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results form the Epidemiological Catchement Area (ECA) Study. JAMA. 1990;264(19):2511-2518.
2. Kessler RC, Crum RM, Warner LA, et al. Life-time co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54(4):313-321.
3. Frye MA, Altshuler LL, McElroy SL, et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry. 2003;160(5):883-889.
4. Winokur G, Turvey C, Akiskal H, et al. Alcoholism and drug abuse in three groups - bipolar I, unipolars, and their acquaintances. J Affect Disord. 1998;50(2-3):81-89.
5. Brady KT, Lydiard RB. Bipolar affective disorder and substance abuse. J Clin Psychopharmacol. 1992;12(Suppl 1):17S-22S.
6. Tohen M, Greenfield SF, Weiss R, Zarate CA, Vagge LM. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harv Rev Psychiatry. 1988;6(3):133-141.
7. Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. 2003;64(6):680-90.
8. Brady KT. Difficulties in diagnosis and management of bipolar disorder: three case presentations. J Clin Psychiatry. 2000;61(Suppl 13):32-37.
9. Mukherjee S, Shukla S, Woodle J, Rosen AM, Olarte S. Misdiagnosis of schizophrenia in bipolar patients: a multi-ethnic comparison. Am J Psychiatry. 1983;140(12):1571-1574.
10. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effects of anti-depressants: a naturalistic study. J Clin Psychiatry. 2000;61(10):804-808.
11. Dalton EJ, Gate-Carter TD, Mundo E, et al. Suicide risk in bipolar patients: the role of comorbid substance use disorders. Bipolar Disord. 2003;5(1):58-61.
12. Potash JB, Kane HS, Chiu YF, et al. Attempted suicide and alcoholism in bipolar disorder: clinical and familial relationships. Am J Psychiatry. 2000;157(12):2048-2050.
13. Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv. 2002;53(7):861-867.
14. RachBeisel J, Scott J, Dixon L. Co-occuring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999;50(11):2427-1434.
15. Cruess DG, Evans DL, Repetto MJ, et al. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry. 2003;54(3):307-316.
16. Solomon DA, Keitner GI, Miller IW, Shea MT, Keller MB. Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry. 1995;56(1):5-13.
17. Leverich GS, Nolen WA, Rush AJ, et al. The Stanley Foundation Bipolar Treatment Outcome Network, I: longitudinal methodology. J Affect Disord. 2001;67(1-3):33-44.
18. Geller B, Cooper TB, Sun K, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance abuse dependency. J Am Acad Child Adoles Psychiatry. 1998;37(2):171-178.
19. Brady KT, Sonne SC, Anton R, et al. Valproate in the treamtent of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995;56(3):118-121.
20. Bowden CL. Clinical correlates of therapeutic response in bipolar disorder. J Affect Disord. 2001;67(1-3):257-265.
21. Brown ES, Nejtek VA, Perantie DC, Orsulak PJ, Bobadilla L. Lamotrigine in patients with bipolar disorder and cocaine dependence. J Clin Psychiatry. 2003;64(2):197-201.
22. Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet. 2003;361(9370):1677-1685.
23. Scheller-Gilkey G, Woolwine BJ, Cooper I, et al. Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics. Am J Drug Alcohol Abuse. 2003;29(3):553-566.
24. Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 2002;4(6):406-411.
25. Maxwell S, Shinderman MS. Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness. J Addict Dis. 2000;19(3):61-69.
26. Petrakis IL, Leslie D, Rosenheck R. Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs. Alcohol Clin Exp Res. 2003;27(11):1780-1784.
27. Johnson BA, Ait-Daoud N, Ma JZ, Wang Y. Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals. Alcohol Clin Exp Res. 2003;27(11):1773-1779.